| Product Code: ETC9413433 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Sarilumab Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Sarilumab Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Sarilumab Market - Industry Life Cycle |
3.4 South Korea Sarilumab Market - Porter's Five Forces |
3.5 South Korea Sarilumab Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.6 South Korea Sarilumab Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.7 South Korea Sarilumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 South Korea Sarilumab Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 South Korea Sarilumab Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 South Korea Sarilumab Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
4 South Korea Sarilumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in South Korea |
4.2.2 Growing adoption of advanced biologic therapies in the healthcare sector |
4.2.3 Favorable government policies supporting the use of innovative treatments |
4.3 Market Restraints |
4.3.1 High cost associated with sarilumab treatment |
4.3.2 Stringent regulatory requirements for approval and market access |
4.3.3 Competition from existing and new biologic therapies in the market |
5 South Korea Sarilumab Market Trends |
6 South Korea Sarilumab Market, By Types |
6.1 South Korea Sarilumab Market, By End-Users |
6.1.1 Overview and Analysis |
6.1.2 South Korea Sarilumab Market Revenues & Volume, By End-Users, 2021- 2031F |
6.1.3 South Korea Sarilumab Market Revenues & Volume, By Clinic, 2021- 2031F |
6.1.4 South Korea Sarilumab Market Revenues & Volume, By Hospital, 2021- 2031F |
6.1.5 South Korea Sarilumab Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Korea Sarilumab Market, By Demographic |
6.2.1 Overview and Analysis |
6.2.2 South Korea Sarilumab Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.3 South Korea Sarilumab Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.3 South Korea Sarilumab Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 South Korea Sarilumab Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.3.3 South Korea Sarilumab Market Revenues & Volume, By Community-acquired Pneumonia, 2021- 2031F |
6.3.4 South Korea Sarilumab Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Korea Sarilumab Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 South Korea Sarilumab Market Revenues & Volume, By Antirheumatic, 2021- 2031F |
6.4.3 South Korea Sarilumab Market Revenues & Volume, By Interleukin-6 Receptor Antagonist, 2021- 2031F |
6.4.4 South Korea Sarilumab Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.5 South Korea Sarilumab Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 South Korea Sarilumab Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.5.3 South Korea Sarilumab Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 South Korea Sarilumab Market, By Dosage |
6.6.1 Overview and Analysis |
6.6.2 South Korea Sarilumab Market Revenues & Volume, By Injection, 2021- 2031F |
6.6.3 South Korea Sarilumab Market Revenues & Volume, By Solution, 2021- 2031F |
7 South Korea Sarilumab Market Import-Export Trade Statistics |
7.1 South Korea Sarilumab Market Export to Major Countries |
7.2 South Korea Sarilumab Market Imports from Major Countries |
8 South Korea Sarilumab Market Key Performance Indicators |
8.1 Patient adherence rate to sarilumab treatment |
8.2 Number of healthcare facilities offering sarilumab therapy |
8.3 Rate of adverse events reported for sarilumab treatment |
8.4 Average time to market approval for new indications of sarilumab |
8.5 Patient satisfaction and quality of life improvement post-sarilumab treatment |
9 South Korea Sarilumab Market - Opportunity Assessment |
9.1 South Korea Sarilumab Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.2 South Korea Sarilumab Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.3 South Korea Sarilumab Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 South Korea Sarilumab Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 South Korea Sarilumab Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 South Korea Sarilumab Market Opportunity Assessment, By Dosage, 2021 & 2031F |
10 South Korea Sarilumab Market - Competitive Landscape |
10.1 South Korea Sarilumab Market Revenue Share, By Companies, 2024 |
10.2 South Korea Sarilumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here